Jinhai Medical Technology Limited (HKG:2225)

Jinhai Medical Technology Statistics

Total Valuation

HKG:2225 has a market cap or net worth of HKD 11.85 billion. The enterprise value is 11.72 billion.

Market Cap	11.85B
Enterprise Value	11.72B

Important Dates

The last earnings date was Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2225 has 5.29 billion shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class	5.29B
Shares Outstanding	5.29B
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	47.83%
Owned by Institutions (%)	0.03%
Float	2.76B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	42.32
PB Ratio	37.68
P/TBV Ratio	38.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-113.41
EV / Sales	41.86
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.29.

Current Ratio	1.84
Quick Ratio	1.75
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-26.68

Financial Efficiency

Return on equity (ROE) is -41.05% and return on invested capital (ROIC) is -59.86%.

Return on Equity (ROE)	-41.05%
Return on Assets (ROA)	-15.24%
Return on Invested Capital (ROIC)	-59.86%
Return on Capital Employed (ROCE)	-33.46%
Weighted Average Cost of Capital (WACC)	4.25%
Revenue Per Employee	611,425
Profits Per Employee	-225,671
Employee Count	458
Asset Turnover	0.63
Inventory Turnover	13.54

Taxes

In the past 12 months, HKG:2225 has paid 1.41 million in taxes.

Income Tax	1.41M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +64.71% in the last 52 weeks. The beta is 0.00, so HKG:2225's price volatility has been lower than the market average.

Beta (5Y)	0.00
52-Week Price Change	+64.71%
50-Day Moving Average	1.96
200-Day Moving Average	1.40
Relative Strength Index (RSI)	61.12
Average Volume (20 Days)	9,980,740

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2225 had revenue of HKD 280.03 million and -103.36 million in losses. Loss per share was -0.02.

Revenue	280.03M
Gross Profit	43.50M
Operating Income	-108.98M
Pretax Income	-103.85M
Net Income	-103.36M
EBITDA	-85.98M
EBIT	-108.98M
Loss Per Share	-0.02

Balance Sheet

The company has 222.58 million in cash and 90.21 million in debt, with a net cash position of 132.36 million or 0.03 per share.

Cash & Cash Equivalents	222.58M
Total Debt	90.21M
Net Cash	132.36M
Net Cash Per Share	0.03
Equity (Book Value)	314.44M
Book Value Per Share	0.06
Working Capital	178.02M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	23.02M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 15.54%, with operating and profit margins of -38.92% and -36.91%.

Gross Margin	15.54%
Operating Margin	-38.92%
Pretax Margin	-37.09%
Profit Margin	-36.91%
EBITDA Margin	-30.70%
EBIT Margin	-38.92%
FCF Margin	n/a

Dividends & Yields

HKG:2225 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	-0.11%
Earnings Yield	-0.87%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 12, 2024. It was a forward split with a ratio of 4.

Last Split Date	Dec 12, 2024
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1